BUSINESS● LOWOct 8 · Oct 8, 2026, 4:43 PM
Rocket Pharma upgraded at Goldman Sachs on Danon disease therapy
Seeking Alpha Tech · global
Rocket Pharma received an upgrade from Goldman Sachs due to its Danon disease therapy. This indicates positive analyst sentiment regarding the company's pharmaceutical developments.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS25m agoCompass sues California's listing service over anti-competitive rules - reportSeeking Alpha TechBUSINESS25m agoTech stocks drag Nasdaq 2% lower; sheds over 4% for the weekSeeking Alpha Tech